Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study.
about
Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populationsAlzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studiesBlood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicabilityBinswanger's disease: toward a diagnosis agreement and therapeutic approachNeuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke.Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus reportCSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease.2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease?Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds.Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy.White Matter Lesions Are Not Related to β-Amyloid Deposition in an Autopsy-Based Study.Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Recent updates on subcortical ischemic vascular dementia.Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samplesNeurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis.Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.Cerebral Small Vessel Disease Is Associated with Dysregulation in the Ubiquitin Proteasome System and Other Major Cellular Pathways in Specific Brain Regions.Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development.Tau proteins in the temporal and frontal cortices in patients with vascular dementia.Serum neurofilament light is sensitive to active cerebral small vessel disease.Cerebrospinal fluid biomarkers and white matter lesions: can we know more?Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study.Progression from mild to pronounced MCI is not associated with cerebrospinal fluid biomarker deviations.Cerebrospinal fluid β-amyloid42 and neurofilament light relate to white matter hyperintensities.Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden.Impaired Neurofilament Integrity and Neuronal Morphology in Different Models of Focal Cerebral Ischemia and Human Stroke Tissue.
P2860
Q24186302-96F82A3A-391F-4D6B-8B32-7B46A099DED4Q26798325-39A83D22-A68F-4CA2-90A5-B0F4674D232CQ28604099-8DD81EBD-ACD5-4639-8249-6532E240722DQ30848732-61B6DF50-CCB7-402D-953A-5610120C4A37Q33689233-7DA157B2-3F46-4E98-A706-7FE4BF96E889Q33721681-C84599FE-8D2A-42A6-A56D-982FA00CC302Q34078579-0D3F4201-1023-4727-B7EF-E92E917C4B3FQ34141104-F483E3E9-7C1B-46A0-88BB-510773BEFF8FQ34149357-85AD2ED8-4BF0-451B-A9B3-C5603A1A0FEFQ34632746-8FFCF359-DA40-47B3-B837-D28C826DC70FQ35606416-252AFA1A-F277-4613-952A-1B96714D2798Q35996619-1A5A9232-438B-4943-B75B-B4079ACEAE23Q36291565-6ADB0FEB-BADB-477D-8748-2EB4C7B97847Q36538745-B6D6E07C-EA67-466D-99EA-CFB312915BD2Q37524486-9A64CA22-DDDC-463D-A9A4-6DD822E96467Q37653889-DE7FF47F-2193-4281-B01D-F4E404AE40EDQ37690301-E9D6AC86-F6F7-4510-ADB3-BA8F1B9F0F19Q39219451-5BB8210C-C73D-4777-B1C7-0FEED0C6C7D4Q41907099-2978776A-1CA0-48EE-AE69-117005400353Q42513691-B7CC3687-EFA0-4167-8099-ADEF4459E95DQ42656279-DD176B84-E710-4C4A-8E8C-9488D052D568Q46788633-7E0B4427-290C-4556-B09B-5762A9C5CC0FQ47631966-CB2F6B96-0A43-4133-B41A-55C75A9FCE17Q48365735-B2313767-28A6-4FC5-AD17-73049C5FCE5EQ48398819-F58700B6-7611-45F5-A062-CF65BF72906DQ50984412-9EB6C621-79F4-4F12-B2B0-F52C3A72B388Q52558592-75295EBC-FC2D-4E85-9BD4-07053460E996Q55028222-723B910E-ED3B-4125-AF3C-36A08C8A75D6Q55247269-234692C2-93C1-4C02-9716-ADBC9E02F7A6Q55412964-2109EE13-0B83-466A-BF20-87E77675BE3E
P2860
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cerebrospinal fluid biomarkers ...... results from the LADIS study.
@ast
Cerebrospinal fluid biomarkers ...... results from the LADIS study.
@en
type
label
Cerebrospinal fluid biomarkers ...... results from the LADIS study.
@ast
Cerebrospinal fluid biomarkers ...... results from the LADIS study.
@en
prefLabel
Cerebrospinal fluid biomarkers ...... results from the LADIS study.
@ast
Cerebrospinal fluid biomarkers ...... results from the LADIS study.
@en
P2093
P2860
P50
P1476
Cerebrospinal fluid biomarkers ...... results from the LADIS study.
@en
P2093
D Inzitari
E van Straaten
S Syversen
P2860
P304
P356
10.1111/J.1468-1331.2009.02808.X
P577
2009-10-21T00:00:00Z